CBD Effective as Adjunctive Therapy for Psychosis, Study Finds
NORML | December 22, 2017 LONDON, UK — The daily administration of CBD (cannabidiol) as an adjunctive therapy mitigates psychotic symptoms in patients with schizophrenia, according to clinical trial data…
